Astellas Pharma
Astellas is committed to turning innovative science into VALUE for patients.
12296 employees · est. 2005
ITM Isotope Technologies Munich SE
Delivering the promise of radiopharmaceuticals to patients.
661 employees · est. 2004 · Germany
ITM Isotope Technologies Munich SE is the older company (2005 vs 2004); Astellas Pharma is the larger of the two.
Side-by-Side Comparison
| Metric | Astellas Pharma | ITM Isotope Technologies Munich SE |
|---|---|---|
| Founded | ||
| Founded | 2005 | 2004 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Germany |
| Employees | ||
| Employees | 12296 larger | 661 |
| Industry | ||
| Industry | Not tracked yet | Biopharma, Biotechnology, Medical Devices |
| Funding Stage | ||
| Funding Stage | IPO | Private Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Research and Development, Drug Discovery, Clinical Trials, Manufacturing and Supply, Digital Transformation, External Funding and Partnerships | Targeted diagnostic and therapeutic radiopharmaceuticals, Precision diagnostics and therapeutics, Radioisotope-based cancer treatment |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients, Medical Researchers, Pharmaceutical Organizations, Investors | Patients with hard-to-treat tumors, Oncologists, Healthcare institutions, Clinical researchers |
| Taxonomy | ||
| Taxonomy | Life Sciences, Pharmaceuticals, Oncology, Ophthalmology, Urology, Immunology, Women's Health, Immuno-Oncology, Gene Therapy, Mitochondria, Blindness And Regeneration, Targeted Protein Degradation, Anticancer Agents, Overactive Bladder Treatment, Organ Transplantation | Radiopharmaceuticals, Precision Oncology, Cancer Therapeutics, Targeted Radionuclide Therapy, Theranostics, Radioisotopes, Neuroendocrine Cancers, Bone Metastases Treatment, GMP Manufacturing, Medical Radionuclides, Clinical Development, Global Supply Network, Marketing Authorization, Radioisotope Platform, Safety And Efficacy Standards |
| Website | ||
| Website | astellas.com | itm-radiopharma.com |
About Astellas Pharma
Astellas Pharma, founded in 2005, stands as a prominent player in the global life sciences arena, dedicated to translating innovative science into value for patients. Their slogan, "Astellas is committed to turning innovative science into VALUE for patients," encapsulates their mission of leveraging...
About ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE, founded in 2004, is a German leader in the biopharma, biotechnology, medical devices, and pharmaceutical industries. The company's slogan, "Delivering the promise of radiopharmaceuticals to patients," emphasizes its commitment to developing cutting-edge radiopharm...
We will tell you when either one moves
BounceWatch watches Astellas Pharma and ITM Isotope Technologies Munich SE for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Astellas Pharma and ITM Isotope Technologi... — by email.
Frequently Asked Questions
Compare Astellas Pharma with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Astellas Pharma on 11 Mar 2026, and ITM Isotope Technologies Munich SE on 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
